Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

738 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Randomized phase II trial of carboplatin + nab-paclitaxel versus cisplatin + gemcitabine for chemotherapy-naïve squamous cell carcinoma: North Japan lung cancer study group 1302.
Kawashima Y, Harada T, Fujita Y, Nakagawa T, Watanabe K, Morikawa N, Takamura K, Kanazawa K, Kuda T, Usui K, Sekine A, Inoue A, Sugawara S. Kawashima Y, et al. Among authors: kanazawa k. Int J Clin Oncol. 2021 Mar;26(3):515-522. doi: 10.1007/s10147-020-01828-1. Epub 2020 Nov 13. Int J Clin Oncol. 2021. PMID: 33184754 Clinical Trial.
[Amiodarone-induced pneumonitis associated with marked eosinophilia in BALF].
Sato S, Watanabe K, Ishida T, Yoshikawa M, Kanazawa K, Saito J, Ohtsuka Y, Suzuki H, Maruyama Y, Munakata M. Sato S, et al. Among authors: kanazawa k. Nihon Naika Gakkai Zasshi. 2006 Feb 10;95(2):356-8. doi: 10.2169/naika.95.356. Nihon Naika Gakkai Zasshi. 2006. PMID: 16536086 Japanese. No abstract available.
Expression of secretoglobin3A2 (SCGB3A2) in primary pulmonary carcinomas.
Tachihara-Yoshikawa M, Ishida T, Watanabe K, Sugawara A, Kanazawa K, Kanno R, Suzuki T, Niimi T, Kimura S, Munakata M. Tachihara-Yoshikawa M, et al. Among authors: kanazawa k. Fukushima J Med Sci. 2008 Dec;54(2):61-72. doi: 10.5387/fms.54.61. Fukushima J Med Sci. 2008. PMID: 19418968 Free PMC article.
Randomized phase II trial of uracil/tegafur and cisplatin versus vinorelbine and cisplatin with concurrent thoracic radiotherapy for locally advanced unresectable stage III non-small-cell lung cancer: NJLCG 0601.
Sugawara S, Maemondo M, Tachihara M, Inoue A, Ishimoto O, Sakakibara T, Usui K, Watanabe H, Matsubara N, Watanabe K, Kanazawa K, Ishida T, Saijo Y, Nukiwa T; North Japan Lung Cancer Study Group. Sugawara S, et al. Among authors: kanazawa k. Lung Cancer. 2013 Jul;81(1):91-6. doi: 10.1016/j.lungcan.2013.04.010. Epub 2013 May 1. Lung Cancer. 2013. PMID: 23643176 Clinical Trial.
Phase II trial of carboplatin and pemetrexed as first-line chemotherapy for non-squamous non-small cell lung cancer, and correlation between the efficacy/toxicity and genetic polymorphisms associated with pemetrexed metabolism: Hokkaido Lung Cancer Clinical Study Group Trial (HOT) 0902.
Kanazawa K, Yokouchi H, Wang X, Ishida T, Fujita Y, Fujiuchi S, Harada T, Harada M, Takamura K, Oizumi S, Kinoshita I, Katsuura Y, Honjo O, Kojima T, Dosaka-Akita H, Isobe H, Munakata M, Nishimura M; Hokkaido Lung Cancer Clinical Study Group. Kanazawa K, et al. Cancer Chemother Pharmacol. 2014 Dec;74(6):1149-57. doi: 10.1007/s00280-014-2589-3. Epub 2014 Oct 8. Cancer Chemother Pharmacol. 2014. PMID: 25294632 Clinical Trial.
The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial): study protocol for a randomized controlled trial.
Inoue T, Takagi H, Owada Y, Watanabe Y, Yamaura T, Fukuhara M, Muto S, Okabe N, Matsumura Y, Hasegawa T, Osugi J, Hoshino M, Higuchi M, Shio Y, Yokouchi H, Kanazawa K, Ohbuchi K, Fukushima T, Munakata M, Suzuki H. Inoue T, et al. Among authors: kanazawa k. Trials. 2017 Oct 18;18(1):485. doi: 10.1186/s13063-017-2227-6. Trials. 2017. PMID: 29047408 Free PMC article. Clinical Trial.
738 results